Call for Abstracts

Only online submission via the Internet using UMIN (University hospital Medical Information Network) is acceptable. You may check, modify, and delete your abstract as many times as you wish during the abstract submission period.
Please also read the description of the guide for the General Session.

SUBMISSION PERIOD

Tuesday, August 9, 2022 - ~~Wednesday, September 14, 2022~~

~~Extended to Wednesday, September 21~~

Extended to Friday, September 30

AUTHOR

The first author must be a member of the Japan Epidemiological Association (JEA) except for invited sessions.
Membership number is required to submit an abstract. If you are not a member of the JEA, please complete the admission procedure. Please contact the Secretariat of the JEA (jea@jeaweb.jp) for membership information.
If you have not paid the annual membership fee up to 2022, and please make sure to pay it by Friday, September 30, 2022.

PASSWORD

Please decide on a password from 6 to 8 half-width characters in advance.
For security reasons, we cannot respond to inquiries about passwords. Please be sure to remember your password.

REGISTRATION NOTIFICATION

Registration notification will be sent to the e-mail address provided in the abstract submission form.
If you do not receive an e-mail, please check the "Confirm/Revise" section, as the registered e-mail address may be incorrect.
If you do not receive an e-mail for other reasons, or if you have trouble submitting your abstract, please contact the Secretariat of the 33rd Annual Meeting of the JEA (jea33@nta.co.jp).
Accepted abstracts will be posted on the website.

ETHICAL REVIEW CONFIRMATION

When registering an abstract for presentation at the Annual Meeting, the JEA confirms whether the abstract has been approved for ethical review per the "Ethical Guidelines for Life Sciences and Medical Research Involving Human Subjects" and/or other guidelines or whether ethical review is not required.
Please note that if your research requires ethical review and has not been approved, you will not be able to register your abstract.
We recommend that you prepare the information of Ethics review committee name, Approval date, and Approval No at hand before starting abstract submission, if your research requires ethical review.
You should confirm whether or not an ethics review is required, or if necessary, and please make inquiries to the ethics review committee of your institution.
The JEA does not make decisions on behalf of the researcher or the ethics review committee.

CONFLICT OF INTEREST (COI)

The first author, on behalf of all co-authors, is required to declare his/her financial relationship with "companies or commercial organizations related to the presentation" for the past three years from the time of registration of the abstract.
Please be sure to read the "Policy for Conflict of Interest in Epidemiological Research", JEA's Bylaws for the policy
(https://jeaweb.jp/files/about/coi/en_COI_policy_saisoku_20211105.pdf) and use the "COI disclosure form".
The first author is required, but co-authors are not required if there is no COI to be disclosed.
If co-authors have COI, please combine the COI disclosure forms of the first author and all co-authors into a single PDF file.
We recommend that you prepare the PDF file of COI disclosure forms before starting abstract submission.

COI disclosure form can be downloaded below.

COI disclosure form

After completing the abstract submission, the COI submission form will come up. I am sorry that the COI submission form is only Japanese because of technical limitations. If you have difficulty uploading the COI form by the system, please send the COI disclosure form by e-mail to the Meeting Secretariat: jea33@nta.co.jp.
Please refer to the "Example of declaration in slides" (JEA Format 1 https://jeaweb.jp/files/about/coi/COI_format1_en_20190610.pdf ) and describe the COI status on your slides or posters at the time of presentation.
If you have any questions about the policy and JEA's Bylaws for conflicts of interest, please contact the Secretariat of the JEA (jea@jeaweb.jp).

SUBMISSION SYSTEM

This submission system has been tested with the latest versions of Firefox, Google Chrome, Microsoft Edge, and Safari. For Safari, the system is compatible with ver. 2.0.3 (417.9.2) or later.

ABSTRACT FORMAT

Tables and figures cannot be inserted into the body of the abstract.
If you wish to include special characters, symbols, superscripts, subscripts, italics, bold, or underlines, please follow the instructions in the abstract submission section and enter HTML tags. In particular, please put the tag <BR> where you want to break the line.
A maximum of 20 authors and 20 affiliated institutions can be registered.
It is convenient to prepare the text of your abstract in advance using a word processing application and paste it into the abstract submission section. We also recommend that you save the abstract text on your computer.
Word limits are as follows:

	Japanese (full-width)	English (half-width)
Title	50 characters	100 letters
Abstract*	1000 characters	2000 letters
Biography (Only invited session) **	250 characters	500 letters

* Include the author's name, affiliation, and all text of the abstract.
** Biography is not included in the number of letters of the abstract.

SSL (Secure Socket Layer)(recommended)

Not secured

CONFIRMATION AND REVISION

After submitting your abstract, please be sure to check the "Confirm/Revise" section to ensure that it has been submitted correctly.
The "Confirm/Revise" section allows you to revise or cancel your abstract after submission.
The Secretariat will not proofread or revise your abstract.
You will not be able to revise abstracts after the abstract submission deadline has passed.
If you wish to cancel your abstract after the abstract submission deadline, please contact the Secretariat of the 33rd Annual Meeting of the JEA (jea33@nta.co.jp).

General Session

One presentation is allowed per person.
Depending on the number of abstracts submitted, we may not be able to meet your request for a presentation method. The conference director will make the final decision.
The acceptance or rejection of your abstract will be notified to the e-mail address you entered when you registered your abstract by the end of November.

PRESENTATION METHOD

General session has 4 presentation methods below:

General session / On-site / Oral
General session / On-site / Poster
General session / On-demand/ Oral
General session / On-demand/ Poster

The "On-site / Oral" registration will be recorded by the Secretariat and used for on-demand view at a later date.
If you choose "On-site/Poster", you can upload your presentation for on-demand as well. After the acceptance and presentation method has been decided, methods to upload for on-demand will be sent.

PRESENTATION FIELDS

Epidemiological methodology
Bioethics
Social epidemiology
Infectious diseases
Cancer
Cardiovascular and renal diseases
Mental health
Nutritional epidemiology
Physical activities
Environmental epidemiology
Occupational health
Maternal and child health
Gerontology and Geriatrics
Genetic/Molecular epidemiology
Disaster epidemiology
Non-communicable diseases (obesity, diabetes, metabolic syndrome)
Global health
Oral health
Others

LANGUAGE

Please select your presentation language (Japanese or English) at the time of abstract submission.
Please use the same language for the abstract and presentation.
If you choose English, your presentation will be given in the English session.

ABSTRACT TEXT

Please structure your abstract as follows (the standard format is as follows):
Background
Objective
Methods
Results
Discussion
Conclusion

Invited Session

The organizer of the session will contact the author directly for more information.
Abstracts may be freely organized.

CONTACT

The 33rd Annual Meeting of the Japan Epidemiological Association, Secretariat.
Plando Japan Inc.
Daimon Urbanist 401, 2-3-6 Shiba-Daimon, Minato-ku, Tokyo 105-0012, JAPAN
TEL +81-03-5470-4401 FAX +81-3-5470-4410 E-mail jea33@nta.co.jp